4//SEC Filing
Santos David A 4
Accession 0001140361-22-047667
CIK 0001034842other
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 4:30 PM ET
Size
12.5 KB
Accession
0001140361-22-047667
Insider Transaction Report
Form 4
Santos David A
EVP, Chief Commercial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-12-28+50,000→ 50,000 totalExercise: $2.42Exp: 2032-01-24→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted an option with a performance-based condition with respect to 50,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On December 28, 2022, it was determined that the performance metric had been met.
- [F2]The option was fully vested on December 28, 2022, the date the determination was made that the performance metric had been met.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001820066
Filing Metadata
- Form type
- 4
- Filed
- Dec 29, 7:00 PM ET
- Accepted
- Dec 30, 4:30 PM ET
- Size
- 12.5 KB